A Florida jury decided that Johnson & Johnson must pay over $13 million in damages in a case involving a patient who died of an overdose of fentanyl after using the company's Duragesic pain patch. Johnson & Johnson spokesperson Greg Panico stated that "we don't think it's the right decision, and we're going to look at our options for an appeal.''
Plaintiffs in the case alleged that the drugmaker knew that manufacturing flaws caused defective patches to be produced, but sold the patches anyway. The lawsuit is the third involving Duragesic to go to trial since 2006, and the company lost the previous two cases as well.
In an August filing with the US Securities and Exchange Commission, Johnson & Johnson disclosed that the drugmaker faces 60 lawsuits related to the treatment. Duragesic patches generated worldwide sales of $1.2 billion in 2007.
To read more Top Story articles, click here.